Skip to main content

Table 1 RR/OR of IHD/AMI for current (vs. never) snus use in never smoking Swedish men

From: Epidemiological evidence relating snus to health – an updated review based on recent publications

Source

Study

Typea

Periodb

Casesc

End-pointd

RR/OR (95% CI)

Adjustment factorse

Bolinder et al. [41]

Construction Workers

PC

1971-74/1985

172

F

1.35 (1.13-1.62)f

age, res

Haglund et al. [42]

Survey of living conditions

PC

1988-89/2003

28

F + NF

0.77 (0.51-1.15)g,h

age, exe, hea, ill, res, ses

Wennberg et al. [43]

VIPi and MONICAj

NCC

1985-99/1999

21

F + NF

0.82 (0.46-1.43)

age, bmi, cho, edu, lei, phy

Huhtasaari et al. [44]

1st MONICAj study

CC

1989-91

59

F + NF

0.89 (0.62-1.29)g,h

age

Huhtasaari et al. [45]

2nd MONICAj study

CC

1991-93

59

F + NF

0.93 (0.65-1.34)f,h

none

Hergens et al. [46]

Two counties

CC

1992-94

10

F + NF

0.73 (0.35-1.50)

age, res

Hansson et al. [20]

Construction Workersk

PC

1978-93/20y

309

F + NF

1.01 (0.90-1.14)

age

 

Malmö diet and cancerl

PC

1991-96/13y

4

F + NF

1.00 (0.37-2.70)

age

 

MONICA N.Sweden

PC

1986-2004/11y

7

F + NF

0.77 (0.35-1.69)

age

 

National March Cohort

PC

1997/9y

0

F + NF

-

age

 

SALTm

PC

1998-2002/8y

21

F + NF

1.56 (0.98-2.48)

age

 

Stockholm Public Health

PC

2002/5y

5

F + NF

1.21 (0.48-3.08)

age

 

Scania Public Health

PC

1991-2000/8y

8

F + NF

1.90 (0.90-4.00)

age

 

WOLFn

PC

1992-98/9y

2

F + NF

3.30 (0.63-17.1)

age

Total

13 estimates

   

Fixedo

1.07 (0.98-1.16)

Het p = 0.06

     

Randomp

1.06 (0.91-1.23)

 

Excluding [41]

12 estimates

   

Fixedo

1.00 (0.91-1.10)

Het p = 0.34

     

Randomp

1.00 (0.88-1.13)

 
  1. aPC = prospective cohort, NCC = nested case-control, CC = case-control.
  2. bFor case-control studies, the period of interviewing is shown. For prospective cohort or nested case-control studies, the baseline period is shown before the /, and either the final year of follow-up or, where this is not available, the mean person-years of follow-up after the /.
  3. cThe number of cases exposed to snus.
  4. dF = fatal, NF = non-fatal.
  5. eAbbreviations used: bmi body mass index, cho cholesterol level, edu education, exe exercise, hea self reported health, ill longstanding illness, lei leisure time, phy physical activity, res area of residence, ses socioeconomic status.
  6. fEstimated from data in source article.
  7. gEstimate is for current v non-current snus users.
  8. hEstimate is for non-current smokers.
  9. iVIP = Vasterbötten Intervention Program.
  10. j MONICA = Multinational Monitoring of trends and determinants in Cardiovascular disease.
  11. kResults supersede those reported earlier [38].
  12. lResults supersede those reported earlier [39].
  13. mSALT = Screening across the lifespan twin study, results supersede those reported earlier [40].
  14. nWOLF = Work, lipids and fibrinogen.
  15. o“Fixed” – the result of the fixed effect meta-analysis is shown on the right followed by the between-study heterogeneity p value (“Het p”).
  16. p“Random” – the result of the random-effects meta-analysis is shown on the right.